Dr. Rangadham Nagarakanti, MD, FACC.

Affiliation: Dr. Nagarakanti is a board certified cardiac electrophysiologist and conducts full time practice in cardiac disorders with specialization in management of cardiac electrophysiology disorders. Dr. Nagarakanti had been a dedicated clinical researcher and was an investigator for several multinational trials such as Randomized Evaluation of Longterm anticoagulation therapy (RE-LY) and efficacy and safety of budiodarone in paroxysmal atrial fibrillation (PASCAL). He has authored more than 40 peer-reviewed articles, abstracts and textbook chapters. He received the “Best paper award” from American heart association for the cardioversion analysis paper in the Circulation journal, which received highest level of citation in 2011.